Many institutions now cover OA publishing costs for affiliated researchers, as part of an OA agreement with Springer Nature. Find out more about OA agreements and whether you may be entitled to publish OA with your fees covered.
Check your eligibility to publish open access with your fees covered
Thematic Series
- World Aids Day
- Retroviruses & the Microbiome
- The multifaceted regulation of transcription in animal and human retroviruses, endogenous retroviruses
- HIV infection of uncommon host cells
- Applications of CRISPR-Cas and genome editing techniques for established and emerging infectious diseases
- Previous Thematic Series
World Aids Day
December 1st marks World AIDS Day, a globally recognized occasion dedicated to raising awareness of the AIDS pandemic and mourning those we have lost.
This cross-journal collection focuses on exploring the effects and consequences of long-term HIV infection, advances in treatment, epidemiological studies and global health, and more.
Retroviruses & the Microbiome
The focus of this issue is to move beyond associations to mechanisms and functional interactions, including both replication-competent and endogenous retroviruses, human and non-human hosts, and implications for homeostasis, disease and/or therapeutics.
Deadline for submissions: 20 May 2024
The multifaceted regulation of transcription in animal and human retroviruses, endogenous retroviruses
Retroviruses are enveloped viruses with a capsid containing two copies of the viral genomic positive sense single-stranded RNA. Retroviruses are responsible for a broad range of diseases in animals and humans, the most common of which is the development of cancers.
HIV infection of uncommon host cells
This collection aims to provide a state of the art critical evaluation of HIV infection of atypical cells, their role in pathogenesis and the challenges that they might present when developing and evaluating approaches towards an HIV cure.
Applications of CRISPR-Cas and genome editing techniques for established and emerging infectious diseases
The simplicity and broad applicability of targeted and programmable genome editing approaches, including but not limited to those based on CRISPR-Cas9, raise the possibility of a new way to treat a variety of infections, as well as numerous therapeutic strategies for common diseases. This series aims to build a collection of articles that will highlight current developments in this area.
Previous Thematic Series
The Capsid Protein, a Master Regulator of HIV-1 Replication
Edited by Felipe Diaz-Griffero
HIV Intervention Using Mouse Models for Viruses
Edited by J Victor Garcia-Martinez and Angela Wahl
Endogenous Retroviruses in Evolution and Disease
Cross-journal collection
HTLV-1: a re-emerging human pathogen
Edited by Genoveffa Franchini and Cynthia Masison
Broadly neutralizing antibodies (bnAbs) against HIV
Edited by Rogier Sanders and Marit van Gils
Measuring HIV-1 persistence in vivo
Edited by Ben Berkhout and Alexander Pasternak
Disruptive technologies in retrovirus research
Edited by Johnson Mak
Articles
-
-
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection
-
Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome
-
Retroviral PBS-segment sequence and structure: Orchestrating early and late replication events
-
HIV-1 with gag processing defects activates cGAS sensing
-
Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
-
Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection
-
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells
-
A reflection on HIV/AIDS research after 25 years
-
Host-virus interaction: a new role for microRNAs
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Announcing the launch of In Review
Retrovirology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Best Retrovirology Paper by a Young Scientist Award 2023
The Best Retrovirology Paper by a Young Scientist Award was introduced in 2020, to award young researchers who have published a paper in Retrovirology in the previous 2 years that made a significant contribution to the field.
It is with great pleasure that we announce the winners for 2023: William McFadden and Alexa Snyder. The winning Retrovirology paper is available here.
William McFadden grew up in Pittsburgh Pennsylvania and graduated from the University of Pittsburgh with bachelor degrees in Molecular Biology and Political Science in 2019. He is now a Ph.D. candidate in Biochemistry, Cell and Developmental Biology (BCDB) program at Emory University, conducting NRSA F31–supported dissertation research in the Sarafianos lab. For his dissertation, he is studying the mechanisms of HIV-1 capsid assembly with various antiviral compounds; since writing the “Rotten to the Core” paper, which was his first review article, he has developed a large interest in scientific writing and communications.
Alexa Snyder, a graduate student at Emory University, conducts research in Dr. Stefan Sarafianos' laboratory. Her work focuses on exploring the mechanisms behind HIV-1 resistance and hypersensitivity to various long-acting antivirals.
Editors-in-Chief
Johnson Mak, PhD, Institute for Glycomics, Griffith University, Australia
Susan Ross, University of Illinois at Chicago, USA
Editor Emeritus
Andrew Lever, PhD, University of Cambridge (Emeritus Professor), UK
Founding Editor
Kuan-Teh Jeang, MD, PhD, National Institutes of Health, USA (1958-2013)
Why publish your article in Retrovirology?
- We welcome research from across the entire field of retroviruses, supporting the research community with a progressive and inclusive approach.
- Ranked among the top virology journals worldwide, we publish high quality research and expert reviews across basic science, translational, and clinical research.
- Our expert and highly responsive team of Editors provides excellent service throughout, with rapid evaluation and publication of research with broad and lasting impact.
- Founded in 2004, we are one of the leading influencers in HIV/AIDS and retrovirus research, reaching a large global audience.
Aims and scope
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on host-pathogen interactions, fundamental mechanisms of replication, immune defenses, animal models, and clinical science relating to retroviruses. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses.
Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-1 is the etiological agent for adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology aims to cover comprehensively all aspects of human and animal retrovirus research.
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.7
5-year Journal Impact Factor: 3.1
Source Normalized Impact per Paper (SNIP): 0.707
SCImago Journal Rank (SJR): 0.845Speed 2023
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 83Usage 2023
Downloads: 932,795
Altmetric mentions: 667